# OnCo record gerhardt-attard (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/gerhardt-attard/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "gerhardt-attard" ;
  schema:name "Gerhardt Attard"@en ;
  schema:description "London oncologist who helped develop abiraterone and led the STAMPEDE analysis showing that two years of abiraterone alongside hormone therapy and radiotherapy improves survival in high-risk localised prostate cancer."@en ;
  schema:url <https://onco.cc/people/gerhardt-attard/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "prostate", "trialist" ;
  schema:jobTitle "Medical oncologist, UCL Cancer Institute and University College London Hospitals" ;
  schema:sameAs <https://orcid.org/0000-0002-4811-7983> ;
  onco:cancers <https://onco.cc/cancers/prostate-high-risk/>, <https://onco.cc/cancers/prostate/> ;
  onco:institutions <https://onco.cc/institutions/uclh/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-stampede-abiraterone-high-risk-attard-lancet-2022/> ;
  schema:affiliation <https://onco.cc/institutions/uclh/> .